 <h1>Hectorol Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>doxercalciferol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about doxercalciferol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Hectorol.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to doxercalciferol: oral capsules, parenteral injection</i></p><p>Side effects include:</p><p>In dialysis patients: Edema,   headache,   malaise,   nausea/vomiting,   dizziness,   dyspnea,   pruritus,   bradycardia.  </p><p>In predialysis patients with stage 3 or 4 CKD: Infection,  chest pain,  constipation,  dyspepsia,  anemia,  dehydration,  depression,  hypertonia,  insomnia,  paresthesia,  increased cough,  dyspnea,  rhinitis. </p><p>Excessive vitamin D intake (early manifestations): Weakness,   headache,   somnolence,   nausea,  vomiting,  dry mouth,   constipation,   bone pain,   metallic taste,   anorexia.  </p><p>Excessive vitamin D intake (late manifestations): Polyuria,   polydipsia   anorexia,   weight loss,   nocturia,   calcific conjunctivitis,   pancreatitis,   photophobia,   rhinorrhea,   pruritus,   hyperthermia,   decreased libido,   increased BUN,   albuminuria,   hypercholesterolemia,   increased serum AST and ALT concentrations,   ectopic calcification,   hypertension,   cardiac arrhythmias,   sensory disturbances,   dehydration,   apathy,   growth arrest,   urinary tract infections.  </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to doxercalciferol: intravenous solution, oral capsule</i></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Edema (34.4%)</p><p><b>Common</b> (1% to 10%): Anorexia, weight increase, dehydration</p><p><b>Frequency not reported</b>: Hypercalcemia, hyperphosphatemia, hypercalciuria<sup>[Ref]</sup></p><p>Early signs and symptoms of hypercalcemia have included weakness, headache, somnolence, nausea, vomiting, dry mouth, constipation, muscle pain, bone pain, metallic taste, and anorexia.</p><p></p><p>Prolonged hypercalcemia may result in polyuria, polydipsia, anorexia, weight loss, nocturia conjunctivitis (calcific), pancreatitis, photophobia, rhinorrhea, pruritus, hyperthermia, decreased libido, elevated blood urea nitrogen (BUN), albuminuria, hypercholesterolemia, elevated serum aspartate transaminase (AST) and alanine transaminase (ALT), ectopic calcification, hypertension, cardiac arrhythmias, sensory disturbances, dehydration, apathy, arrested growth, urinary tract infections, and, rarely, overt psychosis.</p><p></p><p>Hyperphosphatemia may exacerbate hyperparathyroidism.</p><p></p><p>Hypercalciuria may accelerate the onset of renal failure.<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Oversuppression of iPTH may result in adynamic bone syndrome.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Oversuppression of parathyroid hormone<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Bradycardia, chest pain<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea/vomiting (21.3%)</p><p><b>Common</b> (1% to 10%): Dyspepsia, constipation<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (27.9%), dizziness (11.5%)</p><p><b>Common</b> (1% to 10%): Hypertonia, paresthesia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (11.5%)</p><p><b>Common</b> (1% to 10%): Cough increased, rhinitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Malaise (27.9%)</p><p><b>Common</b> (1% to 10%): Abscess<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Sleep disorder, depression</p><p><b>Uncommon</b> (0.1% to 1%): Insomnia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection</p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity reactions (including fatal outcome)</p><p>Hypersensitivity reactions include anaphylaxis with symptoms of angioedema (involving face, lips, tongue, and airway), hypotension, unresponsiveness, chest discomfort, shortness of breath, cardiopulmonary arrest, pruritus, and skin burning sensation.  These reactions may occur separately or together.</p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Hectorol (doxercalciferol)" Genzyme Corporation, Cambridge, MA. </p><h2>More about Hectorol (doxercalciferol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Generic Availability</li>
<li>Drug class: vitamins</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Secondary Hyperparathyroidism</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>